Acute toxicity and patient‐reported symptom score after conventional versus moderately hypofractionated proton therapy for prostate cancer

INTRODUCTION: To confirm the feasibility of hypofractionated proton beam therapy (PBT), we compared the acute adverse event rates and International Prostate Symptom Score (IPSS) in prostate cancer patients treated with hypofractionated versus conventionally fractionated (2.0 Gy relative biological e...

Descripción completa

Detalles Bibliográficos
Autores principales: Iizumi, Takashi, Ishikawa, Hitoshi, Sekino, Yuta, Tanaka, Keiichi, Takizawa, Daichi, Makishima, Hirokazu, Numajiri, Haruko, Mizumoto, Masashi, Nakai, Kei, Okumura, Toshiyuki, Sakurai, Hideyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163454/
https://www.ncbi.nlm.nih.gov/pubmed/34664410
http://dx.doi.org/10.1002/jmrs.551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163454/
https://www.ncbi.nlm.nih.gov/pubmed/34664410
http://dx.doi.org/10.1002/jmrs.551

Ejemplares similares